HEPATITIS B SURFACE ANTIGEN, HEPATITIS B SURFACE ANTIGEN, IMIQUIMOD clinical trials

Effectiveness and Safety of Intra-Dermal Hepatitis B Vaccination after topical application of IMIQUIMOD, in cirrhotic patients, who did not respond to the conventional vaccine regimen: a pilot study

This study looks at a new way to give the Hepatitis B vaccine to people with liver scarring (cirrhosis) who haven't responded to the usual vaccine. It checks if adding a cream called Imiquimod before the vaccine helps, and if this new method is safe.